Supplementary Figure 1 from Dual mTORC1/2 and HER2 Blockade Results in Antitumor Activity in Preclinical Models of Breast Cancer Resistant to Anti-HER2 Therapy

Celina García-García, Yasir H. Ibrahim,Violeta Serra, Maria Teresa Calvo, Marta Guzmán, Judit Grueso,Claudia Aura, José Pérez, Katti Jessen,Yi Liu,Christian Rommel,Josep Tabernero,José Baselga,Maurizio Scaltriti

crossref(2023)

Cited 0|Views0
No score
Abstract
PDF file, 760KB, Biochemical analyses of trastuzumab/lapatinib sensitive cells treated with lapatinib.
More
Translated text
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined